Syndevrx Inc, Corporation just had published form D about $15.00 million debt financing. The date of first sale was 2012-10-25. Syndevrx was able to fundraise $13.41 million. That is 89.40% of the offering. The total fundraising amount was $15.00 million. This form was filed on 2016-07-13. The reason for the financing was: Five percent (5%) fee plus options payable for specified investments.. The fundraising still has about $1.59 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Syndevrx is based in Massachusetts. The firm’s business is Biotechnology. The D form was signed by Bradley J Carver President. The company was incorporated more than five years ago. The filler’s address is: One Broadway, 14Th Floor, Cambridge, Ma, Massachusetts, 02142. Bradley J Carver is the related person in the form and it has address: One Broadway, 14Th Floor, Cambridge, Ma, Massachusetts, 02142. Link to Syndevrx Filing: 000145536416000003.
Analysis of Syndevrx Offering
On average, firms in the Biotechnology sector, sell 73.77% of the total offering amount. Syndevrx sold 89.40% of the offering. The financing is still open. Could this mean that the trust in Syndevrx is high? The average investment offering size for companies in the Biotechnology industry is $3.08 million. The total amount raised is 335.40% bigger than the average for companies in the Biotechnology sector. The minimum investment for this fundraising is set at $0. If you know more about the reasons for the fundraising, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Syndevrx Also
The Form D signed by Bradley J Carver might help Syndevrx Inc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.